Literature DB >> 8763877

Oxygen distributions partly explain the radiation response of human squamous cell carcinomas.

P Okunieff1, J de Bie, E P Dunphy, D J Terris, M Höckel.   

Abstract

The oxygen tension of human tumours has often been thought to alter tumour response to radiation therapy. The purpose of this analysis is to determine to what extent the observed results of radiotherapy fit predictions based on in situ human tumour pO2 distributions. The radiation dose-response curve for patients treated with radiation alone for squamous cell cancers of the cervix and oropharynx were calculated based on published data. pO2 histograms were obtained from 30 women with cervical cancer and 11 patients with neck nodes from head and neck cancers. An average of 76 +/- 35 (range 28-174) measurements were made from each patient. Hypoxia was assumed to be a purely dose-modifying factor with a maximum OER of 2.5. Assuming patients are treated with daily radiation doses of 2 Gy, the squamous cell carcinoma alpha/beta ratio is 10 Gy, and that tumours have a mean of 10(8) clonogens, it was possible to estimate tumour control probability. Tumour oxygenation was an extremely important modifier of the slope of the dose-response curve and alone was sufficient to account for the slope of the clinically observed dose-response curve for neck nodes. The response curve for uterine cervical cancers is very shallow, and the oxygen distribution did not completely account for heterogeneity of response of these tumours. The results support the conclusion that oxygen tension distribution is an important modifier of human radiation treatment response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763877      PMCID: PMC2149979     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  30 in total

1.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

2.  Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix.

Authors:  C M West; S E Davidson; R D Hunter
Journal:  Int J Radiat Biol       Date:  1989-11       Impact factor: 2.694

3.  Blood flow, tissue oxygenation, pH distribution, and energy metabolism of murine mammary adenocarcinomas during growth.

Authors:  P Vaupel; P Okunieff; L J Neuringer
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

4.  Seduced by oxygen.

Authors:  E Finkelstein; E Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-01       Impact factor: 7.038

Review 5.  Sensitization of hypoxic tumour cells--clinical experience.

Authors:  J Overgaard
Journal:  Int J Radiat Biol       Date:  1989-11       Impact factor: 2.694

Review 6.  Potential methods for predicting tumor radiocurability.

Authors:  L J Peters; W A Brock; T Johnson; R E Meyn; P J Tofilon; L Milas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

7.  Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

Authors:  T Girinski; M H Pejovic-Lenfant; J Bourhis; F Campana; J M Cosset; C Petit; E P Malaise; C Haie; A Gerbaulet; D Chassagne
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-01       Impact factor: 7.038

8.  Radiation therapy alone or combined with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix (stages IB, IIA, IIB).

Authors:  C A Perez; M S Kao
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

9.  Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.

Authors:  H D Suit; R Sedlacek; G Silver; C C Hsieh; E R Epp; F Q Ngo; W K Roberts; L Verhey
Journal:  Radiat Res       Date:  1988-12       Impact factor: 2.841

Review 10.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

View more
  2 in total

1.  Uptake rate of cationic mitochondrial inhibitor MKT-077 determines cellular oxygen consumption change in carcinoma cells.

Authors:  John L Chunta; Kerry S Vistisen; Zeinab Yazdi; Rod D Braun
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

2.  First-In-Human Study in Cancer Patients Establishing the Feasibility of Oxygen Measurements in Tumors Using Electron Paramagnetic Resonance With the OxyChip.

Authors:  Philip E Schaner; Benjamin B Williams; Eunice Y Chen; Jason R Pettus; Wilson A Schreiber; Maciej M Kmiec; Lesley A Jarvis; David A Pastel; Rebecca A Zuurbier; Roberta M DiFlorio-Alexander; Joseph A Paydarfar; Benoit J Gosselin; Richard J Barth; Kari M Rosenkranz; Sergey V Petryakov; Huagang Hou; Dan Tse; Alexandre Pletnev; Ann Barry Flood; Victoria A Wood; Kendra A Hebert; Robyn E Mosher; Eugene Demidenko; Harold M Swartz; Periannan Kuppusamy
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.